viewVenus Metals Corporation Ltd

Venus Metals identifies 10 priority gold anomalies at Sandstone-Bellchambers

An Xcite airborne electromagnetic survey has defined 25 anomalies of which 10 are high-priority targets.

Venus Metals Corporation Ltd - Venus Metals Corporation delineates gold anomalies at Sanstone – Bellchambers Gold Project
Modelling of the high‐priority EM targets is in progress

Venus Metals Corporation Ltd (ASX:VMC) has delineated conductive trends and anomalies associated with gold mineralisation at Sandstone-Bellchambers Gold Project in Western Australia.

A recent Xcite airborne electromagnetic (HEM) survey has defined 25 anomalies of which 10 are high-priority targets.

These high-priority targets are along the interpreted mineralised Western Ridge-Mickey Well trend.

Targets correlate to historical anomalies

Of high significance are mid- to late-time anomalies BC20 to BC24, which have been delineated in the south of the survey area and represent discrete EM responses ranging in strike length from 200 metres to 400 metres.

Targets BC20 and BC24 appear to correlate with historical geochemical gold anomalies defined by Aquila and more recent reconnaissance geochemical sampling by Venus returned up to 3.38 g/t gold at BC24.

Image showing high priority southern targets with geochemical results

Recent geological field studies underscore the importance of stratigraphic controls on gold mineralisation along the Western Ridge-Mickey Well gold trend, where gold mineralisation occurs within sheared sediments along the contact with Banded Iron Formation (BIF) and mafic to ultramafic rocks.

Modelling of the high priority EM targets is in progress and drill testing of potential conductive target plates is scheduled to begin as soon as possible.

Quick facts: Venus Metals Corporation Ltd

Price: 0.2 AUD

Market: ASX
Market Cap: $30.22 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Venus Metals Corporation Ltd named herein, including the promotion by the Company of Venus Metals Corporation Ltd in any Content on the Site,...


Orthocell's Paul Anderson hails FDA approval for dental bone and tissue...

Orthocell Ltd's (ASX:OCC) Paul Anderson caught up with Proactive's Andrew Scott soon after announcing they've received Food and Drug Administration’s (FDA) 510(k) clearance to market and supply its CelGro collagen medical device for dental bone and tissue regeneration procedures in the US....

2 days, 18 hours ago

2 min read